Germany · 
What does nrw.bank invest in?
nrw.bank invests most often at Series A and Series B (64% of the rounds on record), in sectors such as Energy, Pharmaceutical and Biotechnology.
nrw.bank highlights
- 01
3 cheques in the last 12 months
- 02
Mostly Series A and Series B: 64% of its rounds
- 03
1 exits from the portfolio
What they do
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Sectors
- EnergyPharmaceuticalBiotechnology
- Based in
- Düsseldorf, Germany
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first30 appearances
- 2026
3 rounds
- Oct
- Sept
- Jun
- 2025
4 rounds
- Aug
- Jul
- Apr
- Mar
- 2019
1 round
- Oct
- 2018
1 round
- Oct
- 2015
3 rounds
- Nov
- Nov
- Mar
- 2014
4 rounds
- Nov
- Oct
- Jul
- May
- 2013
2 rounds
- Jun
- Mar
- 2011
3 rounds
- Jul
- Jun
- Feb
- 2010
5 rounds
- Sept
- May
- Apr
- Feb
- Feb
- 2008
1 round
- Aug
- 2007
1 round
- Oct
- 2006
2 rounds
- Jul
- Jun
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 7 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
Funds they back
1 fund commitment on record
- Managers
- 1
Every fund on record that it has committed money to, and the managers who invest it.Source: fund news.
Managers it backs most
Most recent commitments
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
DIREVO Industrial BiotechnologyBought by Bayer HealthCare$297MSept 2008
An exit counts when it came after the firm's first round in the company. From historical deal records.